Literature DB >> 890365

Family similarities in the age at coronary death in familial hypercholesterolaemia.

A Heiberg, J Slack.   

Abstract

In a combined Norwegian and British study of the age at death from coronary heart disease of heterozygotes for familial hypercholesterolaemia (FH) the correlation coefficients within families for 43 sib pairs was 0-70 and for 14 first cousin pairs 0-61. There was no significant correlation between the age at death and serum cholesterol concentration in either series. The intrafamilial correlations suggest that information about the age at death from coronary heart disease in heterozygotes within families may have some prognostic value and may also be interpreted as evidence for genetic heterogeneity in FH.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890365      PMCID: PMC1630857          DOI: 10.1136/bmj.2.6085.493

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY.

Authors:  W B KANNEL; T R DAWBER; G D FRIEDMAN; W E GLENNON; P M MCNAMARA
Journal:  Ann Intern Med       Date:  1964-11       Impact factor: 25.391

2.  Familial hypercholesterolemia, xanthomatosis and coronary heart disease.

Authors:  F H EPSTEIN; W D BLOCK; E A HAND; T FRANCIS
Journal:  Am J Med       Date:  1959-01       Impact factor: 4.965

3.  The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds.

Authors:  A Heiberg; K Berg
Journal:  Clin Genet       Date:  1976-02       Impact factor: 4.438

4.  Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.

Authors:  J Slack
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

5.  A new type of familial hypercholesterolaemia.

Authors:  M J Higgins; D S Lecamwasam; D J Galton
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

6.  Coronary disease in familial hypercholesterolemia.

Authors:  J Jensen; D H Blankenhorn; V Kornerup
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

7.  Inheritance of xanthomatosis and hyper-beta-lipoproteinaemia. A study of 7 large kindreds.

Authors:  A Heiberg
Journal:  Clin Genet       Date:  1976-01       Impact factor: 4.438

8.  The risk of atherosclerotic vascular disease in subjects with xanthomatosis.

Authors:  A Heiberg
Journal:  Acta Med Scand       Date:  1975-10
  8 in total
  12 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Screening for familial hypercholesterolaemia by measurement of apolipoproteins in capillary blood.

Authors:  F Skovby; S Micic; B Jepsen; S O Larsen; B Hansen; L Tegllund; B N Pedersen
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

3.  Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.

Authors:  Matthias Gautschi; Mladen Pavlovic; Jean-Marc Nuoffer
Journal:  JIMD Rep       Date:  2011-09-06

4.  Analyzing the relationship between age at onset and risk to relatives.

Authors:  M C Neale; L J Eaves; J K Hewitt; C J MacLean; J M Meyer; K S Kendler
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

5.  Genetic and environmental variation in serum lipoproteins in relation to coronary heart disease.

Authors:  F W Robertson; A M Cumming
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

6.  European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.

Authors:  H Schuster; S Humphries
Journal:  Clin Investig       Date:  1994-11

7.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

8.  Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.

Authors:  D D Sugrue; I Trayner; G R Thompson; V J Vere; J Dimeson; Y Stirling; T W Meade
Journal:  Br Heart J       Date:  1985-03

9.  Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.

Authors:  H A W Neil; V Seagroatt; D J Betteridge; M P Cooper; P N Durrington; J P Miller; M Seed; R P Naoumova; G R Thompson; R Huxley; S E Humphries
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

10.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Authors:  Andrew Neil; Jackie Cooper; John Betteridge; Nigel Capps; Ian McDowell; Paul Durrington; Mary Seed; Steve E Humphries
Journal:  Eur Heart J       Date:  2008-10-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.